JMP Securities downgraded Deciphera to Market Perform from Outperform after the company entered into an agreement to be acquired by Ono Pharmaceutical for $25.60 per share.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds